A CLINICAL TRIAL TO STUDY THE EFFECT OF THE DRUG BHRINGARAJA CHOORANAM IN PATIENTS HAVING ANAEMIA

EVALUATION OF BHRINGARAJA CHOORANAM FOR PITHA PAANDU (IRON DEFICIENCY ANAEMIA) - AN OPEN CLINICAL STUDY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/12/016554

Enrollment

Registered

2018-12-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Anubava Vaithya Deva Ragasiyam,part 3: 5 Grams of Bhringaraja chooranam is administered twice a day with honey for 48 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Hb between 7-10% grmas Fatigue Loss of appetite Pallor of conjunctiva and nail buds Dyspnoea on exertion Ulceration of mouth Worm infestation

Exclusion criteria

Exclusion criteria: Chronic renal and liver disorders Bleeding disorders Diabetes Mellitus Menorrhagia Haemorrhoids Pregnant and lactating women TB affected individuals HIV positive Megaloblastic anaemia Aplastic anaemia

Design outcomes

Primary

Measure	Time frame
Outcome is mainly assessed by reduction in clinical symptoms supported with 20% increased in Hb and by comparing the investigational parameters before and after treatmentTimepoint: 48 Days	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactDr Sudha V

Government Siddha Medical College

sasirekha.siddha@gmail.com9444832728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026